That memantine, a glutamate blocking agent (of suspect efficacy for this) and generically known to physicians as a "neuroprotective agent" is being touted as an ocular nerve protecting drug for glaucoma is strange indeed. I would ask my ophthalmologist his/her rationale for its use. If the answer doesn't include a specific mechanism of action, I would drop it as a waste of money.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.